Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
EMBC is expected to report earnings to rise 34.00% to 67 cents per share on February 06
Q4'25
Est.
$0.67
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.35
Q1'25
Beat
by $0.17
Q4'24
Beat
by $0.16
The last earnings report on November 25 showed earnings per share of 50 cents, beating the estimate of 46 cents. With 218.11K shares outstanding, the current market capitalization sits at 716.78M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EMBC showed earnings on November 25, 2025. You can read more about the earnings report here.